# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-049042
Filing Date
2023-04-24
Accepted
2023-04-24 16:42:59
Documents
9
Period of Report
2023-06-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm232146-1_def14a.htm | DEF 14A | 666145
2 | GRAPHIC | lg_cognition-4c.jpg | GRAPHIC | 34019
3 | GRAPHIC | ic_mail-bw.gif | GRAPHIC | 2202
4 | GRAPHIC | ic_internet-bw.gif | GRAPHIC | 3916
5 | GRAPHIC | ic_phone-bw.gif | GRAPHIC | 2263
6 | GRAPHIC | ic_meeting-bw.gif | GRAPHIC | 2163
7 | GRAPHIC | ic_tick-bw.gif | GRAPHIC | 1428
8 | GRAPHIC | px_proxy01pg01-4c.jpg | GRAPHIC | 876060
9 | GRAPHIC | px_proxy01pg02-4c.jpg | GRAPHIC | 479029
| Complete submission text file | 0001104659-23-049042.txt |  | 2390520

Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40886 | Film No.: 23840620
SIC: 2836 Biological Products, (No Diagnostic Substances)